[1]原 荣,李 军,南 星,等.陕西省安康和延安两地区妇女HPV感染及型别分布对比研究[J].现代检验医学杂志,2017,32(02):64-66.[doi:10.3969/j.issn.1671-7414.2017.02.017]
　YUAN Rong,LI Jun,NAN Xing,et al.Comparative Study on HPV Infection and Hypotype Distribution between Ankang and Yan'an Area of Shaanxi Province[J].Journal of Modern Laboratory Medicine,2017,32(02):64-66.[doi:10.3969/j.issn.1671-7414.2017.02.017]
点击复制

陕西省安康和延安两地区妇女HPV感染及型别分布对比研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第32卷
期数:
2017年02期
页码:
64-66
栏目:
论著
出版日期:
2017-03-25

文章信息/Info

Title:
Comparative Study on HPV Infection and Hypotype Distribution between Ankang and Yan'an Area of Shaanxi Province
文章编号:
1671-7414(2017)02-064-03
作者:
原 荣; 李 军; 南 星; 燕林青
陕西省肿瘤医院,西安 710061
Author(s):
YUAN Rong; LI Jun; NAN Xing; YAN Lin-qing
Shaanxi Province Tumor Hospital,Xi'an 710061,China
关键词:
人乳头瘤病毒;  宫颈癌;  基因型
分类号:
R373; R181.32
DOI:
10.3969/j.issn.1671-7414.2017.02.017
文献标志码:
A
摘要:
目的 比较安康(陕南)和延安(陕北)两个不同地域人群感染HPV的特性,为宫颈癌的防治提供参考。方法 采用PCR体外扩增和DNA反向斑点杂交技术对2012年7月～2016年7月安康市中心医院7 912例和延安医科大学附属医院3 543例妇女进行HPV基因分型检测,比较两地HPV感染人群年龄、检出率及型别分布。结果 安康HPV总感染率为21.75%(1 721/7 912),延安为41.41%(1 467/3 543)。安康高危型感染阳性率为81.46%(1 402/1 721,包括混合高危感染),延安为86.16%(1 264/1 467); 安康低危型感染阳性率为11.04%(190/1 721),延安为7.23%(106/1467包括混合低危感染); 安康高低危混合感染阳性率为7.50%(129/1 721),延安为6.61%(97/1 467)。两地>60岁组HPV感染率最高,安康为30.41%(104/342),延安为50%(60/120); 两地常见高危型别为HPV16,58和52型,低危型别为HPV6,11和81型。结论两地HPV高发常见型别一致,但是延安HPV感染率显著高于安康(P<0.01),两地各年龄段人群均有较高感染率,原因有待进一步研究。
Abstract:
Objective Compare the HPV infection charactersbetween women in different geographic area of Ankang(south of Shaanxi)and Yanan(north of Shaanxi),to provide evidence based reference for cervical cancer control.Methods PCR amplification in vitro combined reverse dot-blot hybridization assay were used to analyze HPV genotypes of 7 912 cases from Ankang City Center Hospital,and 3 543 cases from Yanan Affiliated Hospital of Yanan Medical University from June 2012 to July 2016,and compared HPV infection rate,age and hypotype distribution of the cases.Results The HPV infection rate of Ankang area was 21.75%(1 721/7 912),and Yanan area was 41.41%(1 402/1 721).The percentage of HPV positive women with high-risk hypotype was 81.46%(1 402/1 721)in Ankang and 86.16%(1 264/1 467)in Yanan,with low-risk hypotype was 11.04%(190/1 721)in Ankang and 7.23%(106/1 467)in Yanan,with high and low risk hypotype was 7.50%(129/147)in Ankang and 6.61%(97/1 467)in Yanan.The women more than 60 year old were higherHPV prevalence age group.The HPV infection rate of this age group was 30.41%(104/342)in Ankang,and 50.00%(60/120)in Yanan.Yanan's HPV infection rate was obviously higher than Ankang.The popular HPV hypotypes in Yanan were same with that in Ankang.The most popular high-risk hypotypes were HPV16,58 and 52,the most popular low-risk hypotypes were 6,11 and 81.ConclusionThe HPV infection rate were rather high in all age group.The most popular HPV hypotypes were same between Ankang and Yanan area.But Yanan's HPV infection rate was obviously higher than Ankang(P<0.01).The causes need further explore.

参考文献/References:

[1] 纪 婵.人乳头状瘤病毒(HPV)感染与宫颈癌发病关系[J].齐齐哈尔医学院学报,2016,37(26):3306-3307. Ji C.The correlation between HPV Infection and cervical cancer[J].Journal of Qiqihar University of Medicine,2016,37(26):3306-3307.
[2] Ronco G,Dillner J,Elfstrom KM,et al.Efficacy of HPV based screening for prevention of invasive cervical cancer:follow-up of four European randomised controlled trials[J].Lancet,2014,383(9916):524-532.
[3] 郑诗丹,王晓平.宫颈癌发病率与患者生活因素的相关性研究[J].齐齐哈尔医学院学报,2016,37(5):572-573. Zheng SD,Wang XP.A study on correlation between prevalence of cervical cancer and sexy activities of cases[J].Journal of Qiqihar University Medicine,2016,37(5):572-573.
[4] 庞小芬,王佳丽,石丹丽,等.人乳头瘤病毒不同亚型感染与宫颈病变程度关系研究[J].广西医学杂志,2016,38(10):1430-1433. Pang XF,Wang JL,Shi DL,et al.A study on the relationship betweendegree of cervical lesions and infection by different hypotypes of HPV[J].Guangxi Medical Journal,2016,38(10):1430-1433.
[5] 王 妍,黄钦贤,林章礼,等.汕头地区女性HPV的感染状况回顾[J].现代检验医学杂志,2015,30(4):122-124. Wang Y,Huang QX,Lin ZL,et al.Review of HPV infection status of the women in Shantou region[J].Journal of Modern Laboratory Medicine,2015,30(4):122-124.
[6] 原 荣,李 军,王一羽,等.陕西省榆林地区和商洛地区HPV感染及亚型分布对比研究[J].现代检验医学杂志,2016,31(6):48-50. Yuan R,Li J,Wang YY,et al.Study on HPV infection rate and hypotype distributionbetween Yulin and Shanglou area in Shaanxi province[J].Journalof Modern Laboratory Medicine,2016,31(6):48-50.
[7] 邵淑娟,岳天孚,张丽琴.女性HPV感染情况及对HPV和HPV疫苗的认知[J].天津医科大学学报,2013,19(2):127-130. Shao SJ,Yue TF,Zhang LQ.HPV infection in female and the cognitionabout HPV and HPV vaccine[J].Journal of Tianjin Medical University,2013,19(2):127-130.
[8] 杨小艺,李 娜,王海宁.1 083例妇女HPV感染状况分析[J].陕西医学杂志,2012,41(6):739-741. Yang XY,Li N,Wang HN.Analysis of HPV infection cases of 1 083 women[J].Journal of Shaanxi Medication,2012,41(6):739-741.
[9] Wang S,Wei H,Wang N,et al.The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China[J].BMC Cancer,2012(12):160.
[10] 张春蕾,华正宇,袁小林,等.大连地区454 例健康体检女性人乳头瘤病毒感染调查[J].中国妇幼保健,2013,28(7):1134-1137. Zhang CL,Hua ZY,Yuan XL,et al.Investigation on 454 women with HPV infection found by health physical examination in Dalian[J].Maternal & Child Health Care of China,2013,28(7):1134-1137.
[11] Mandic A,Usaj Knezevic S,Kapic livkovic T.Tissue expression of VEGFin cervical intraepithelial neoplasia and cervical cancer[J].J Buon,2014,19(4):958-964.

相似文献/References:

[1]孔倩倩a,唐振华,相芬芬a,等.抗HPV18 E6多肽单克隆抗体的制备及鉴定[J].现代检验医学杂志,2016,31(03):30.[doi:10.3969/j.issn.1671-7414.2016.03.009]
　KONG Qian-qiana,TANG Zhen-hua,XIANG Fen-fena,et al.Preparation and Identification of A Peptide Monoclonal Antibody Against Human Papillomavirus 18E6[J].Journal of Modern Laboratory Medicine,2016,31(02):30.[doi:10.3969/j.issn.1671-7414.2016.03.009]
[2]王 冰,朱月蓉,何玉杰,等.血清结合珠蛋白在宫颈癌诊断中的应用研究[J].现代检验医学杂志,2017,32(01):106.[doi:10.3969/j.issn.1671-7414.2017.01.029]
　WANG Bing,ZHU Yue-rong,HE Yu-jie,et al.Application of Haptoglobin in Cervical Cancer Diagnosis[J].Journal of Modern Laboratory Medicine,2017,32(02):106.[doi:10.3969/j.issn.1671-7414.2017.01.029]
[3]林金端a,刘红伟a,张欣宁b,等.Mybl2在不同病变程度宫颈组织中的表达[J].现代检验医学杂志,2017,32(02):141.[doi:10.3969/j.issn.1671-7414.2017.02.039]
　LIN Jin-duana,LIU Hong-weia,ZHANG Xin-ningb,et al.Expression Level and Clinical Significance of Mybl2 in Cervical Tissues[J].Journal of Modern Laboratory Medicine,2017,32(02):141.[doi:10.3969/j.issn.1671-7414.2017.02.039]
[4]韩 伟a,刘文康b,翟卫斌c,等.西安地区男性尿道感染人乳头瘤病毒基因亚型分析[J].现代检验医学杂志,2017,32(03):52.[doi:10.3969/j.issn.1671-7414.2017.03.014]
　HAN Weia,LIU Wen-kangb,ZHAI Wei-binc,et al.Detection of Human Papillomavirus Subtypes in Male Urethra in Xi’an Area[J].Journal of Modern Laboratory Medicine,2017,32(02):52.[doi:10.3969/j.issn.1671-7414.2017.03.014]
[5]原 荣a,李 军a,南 星a,等.陕西省宝鸡和咸阳两地妇女HPV感染现状和类型分析[J].现代检验医学杂志,2017,32(06):145.[doi:10.3969/j.issn.1671-7414.2017.06.001]
　YUAN Ronga,LI Juna,NAN Xinga,et al.HPV Prevalence and Subtypes Analysis of Women in Baoji and Xianyang Area of Shaanxi Province[J].Journal of Modern Laboratory Medicine,2017,32(02):145.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[6]冯 磊,常春红,管晓卿,等.宫颈癌患者血浆miRNA-10b的表达及其临床意义[J].现代检验医学杂志,2018,33(01):52.[doi:10.3969/j.issn.1671-7414.2018.01.001]
　FENG Lei,CHANG Chun-hong,GUAN Xiao-qing,et al.Expression of Plasma miRNA-10b in Patients with Cervical Cancer and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2018,33(02):52.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[7]林丽慧,唐 梅,于春玲,等.HPV阳性宫颈癌和CIN患者血浆miR-150,SCCA及CA125的表达及临床意义[J].现代检验医学杂志,2018,33(02):62.[doi:10.3969/j.issn.1671-7414.2018.02.001]
　LIN Li-hui,TANG Mei,YU Chun-ling,et al.Expression and Clinical Significance of Plasma miR-150,SCCA and CA125 in Patients with HPV Positive Cervical Cancer and CIN[J].Journal of Modern Laboratory Medicine,2018,33(02):62.[doi:10.3969/j.issn.1671-7414.2018.02.001]
[8]刘 娅,贺 巧,佘佳琪.宫颈癌患者治疗前血浆凝血四项指标与生存率的相关性研究[J].现代检验医学杂志,2019,34(03):137.[doi:10.3969/j.issn.1671-7414.2019.03.035]
　LIU Ya,HE Qiao,SHE Jia-qi.Correlation between the Four Indicators of Coagulation andPrognosis in Patients with Cervical Carcinoma before Treatment[J].Journal of Modern Laboratory Medicine,2019,34(02):137.[doi:10.3969/j.issn.1671-7414.2019.03.035]
[9]沈华,盛晓鹃.HPV 阳性宫颈癌组织中IGF2BP2 和RPRD1B 的表达水平及临床价值研究[J].现代检验医学杂志,2023,38(05):121.[doi:10.3969/j.issn.1671-7414.2023.05.023]
　SHEN Hua,SHENG Xiaojuan.Expression and Clinical Value of IGF2BP2 and RPRD1B in HPV Positive Cervical Cancer Tissues[J].Journal of Modern Laboratory Medicine,2023,38(02):121.[doi:10.3969/j.issn.1671-7414.2023.05.023]
[10]徐 幸,王国飞,杨依绡,等.2020~2022年度上海及其他省市临床实验室HPV6型与HPV11型核酸检测室间质量评价结果分析[J].现代检验医学杂志,2024,39(01):179.[doi:10.3969/j.issn.1671-7414.2024.01.034]
　XU Xing,WANG Guofei,YANG Yixiao,et al.Analysis of External Quality Assessment Results for HPV6 and HPV11 Nucleic Acid Testing in Clinical Laboratories of Shanghai and Other Provinces and Cities from 2020 to 2022[J].Journal of Modern Laboratory Medicine,2024,39(02):179.[doi:10.3969/j.issn.1671-7414.2024.01.034]
[11]王 妍,黄钦贤,林章礼,等.汕头地区女性HPV的感染状况回顾[J].现代检验医学杂志,2015,30(04):122.[doi:10.3969/j.issn.1671-7414.2015.04.036]
　WANG Yan,HUANG Qin-xian,LIN Zhang-li,et al.Review of HPV Infection Status of the Women in Shantou Region[J].Journal of Modern Laboratory Medicine,2015,30(02):122.[doi:10.3969/j.issn.1671-7414.2015.04.036]
[12]原荣,李军,王一羽,等.陕西省榆林地区和商洛地区HPV感染及亚型分布对比研究[J].现代检验医学杂志,2016,31(06):48.[doi:10.3969/j.issn.1671-7414.2016.06.013]
　YUAN Rong,LI Jun,WANG Yi-yu,et al.Study on HPV Infection Rate and Hypotype Distribution between Yulin and Shangluo Area in Shaanxi Province[J].Journal of Modern Laboratory Medicine,2016,31(02):48.[doi:10.3969/j.issn.1671-7414.2016.06.013]

备注/Memo

备注/Memo:
基金项目:陕西省科技计划发展项目资助(编号2011K15-06-09)。
作者简介:原 荣(1973-),女,本科,主管技师,主要从事临床病人免疫功能的检测和肿瘤细胞的培养,Tel:15339085844,E-mail:375575774@qq.com。
通讯作者:王一羽(1980-),女,硕士,主管技师,E-mail:maplebuy@.163.com。
更新日期/Last Update: 2017-04-10